Discovery of Novel Noncovalent KRAS G12D Inhibitors through Structure-Based Virtual Screening and Molecular Dynamics Simulations
The development of effective inhibitors targeting the Kirsten rat sarcoma viral proto-oncogene (KRAS<sup>G12D</sup>) mutation, a prevalent oncogenic driver in cancer, represents a significant unmet need in precision medicine. In this study, an integrated computational approach combining...
Main Authors: | Zhenya Du, Gao Tu, Yaguo Gong, Xiangzheng Fu, Qibiao Wu, Guankui Long |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/29/6/1229 |
Similar Items
-
Virtual Screening Based on Machine Learning Explores Mangrove Natural Products as KRAS<sup>G12C</sup> Inhibitors
by: Lianxiang Luo, et al.
Published: (2022-05-01) -
A Breakthrough Brought about by Targeting KRAS<sup>G12C</sup>: Nonconformity Is Punished
by: Wenjuan Ning, et al.
Published: (2022-01-01) -
KRAS inhibitors: going noncovalent
by: Matthias Drosten, et al.
Published: (2022-12-01) -
TEAD Inhibitors Sensitize KRAS<sup>G12C</sup> Inhibitors via Dual Cell Cycle Arrest in KRAS<sup>G12C</sup>-Mutant NSCLC
by: Salvina Laura Tammaccaro, et al.
Published: (2023-04-01) -
The Inhibition of Wnt Restrain KRAS<sup>G12V</sup>-Driven Metastasis in Non-Small-Cell Lung Cancer
by: Pei-Shan Hung, et al.
Published: (2020-03-01)